中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2015年
15期
50-52
,共3页
肖蔼杰%张志辉%林植楷%崔志雄%唐铠
肖藹傑%張誌輝%林植楷%崔誌雄%唐鎧
초애걸%장지휘%림식해%최지웅%당개
胸腔镜%肺癌%淋巴结%可行性%优越性
胸腔鏡%肺癌%淋巴結%可行性%優越性
흉강경%폐암%림파결%가행성%우월성
Radioscopy%Lung cancer%Lymph nodes%Feasibility%Superiority
目的:分析胸腔镜肺癌术中先清扫淋巴结治疗的应用价值,以总结更为有效的胸腔镜肺癌手术方案。方法:将60例拟应用胸腔镜进行肺癌手术治疗的患者随机分A组及B组,每组30例。A组术中先行肿瘤切除后行淋巴结清扫,B组术中先行淋巴结清扫后行肿瘤切除。对比两组术中及术后情况。结果:两组术中出血量、手术时间、淋巴结清扫站数、淋巴结清扫数及术后疼痛评分比较差异均无统计学意义(P>0.05),但B组术后引流量明显少于A组,术后引流时间明显短于A组(P<0.05)。两组治疗前生活质量评分中躯体功能、角色功能、认知功能、情绪功能及社会功能比较差异均无统计学意义(P>0.05),接受术后4周时,两组以上评分均得到有效改善,而B组明显优于A组(P<0.05)。此外,两组术后并发症发生率比较差异无统计学意义(P>0.05)。结论:胸腔镜肺癌术中先于清扫淋巴结可在不降低手术治疗效果的同时,有效地改善患者的术后恢复情况。
目的:分析胸腔鏡肺癌術中先清掃淋巴結治療的應用價值,以總結更為有效的胸腔鏡肺癌手術方案。方法:將60例擬應用胸腔鏡進行肺癌手術治療的患者隨機分A組及B組,每組30例。A組術中先行腫瘤切除後行淋巴結清掃,B組術中先行淋巴結清掃後行腫瘤切除。對比兩組術中及術後情況。結果:兩組術中齣血量、手術時間、淋巴結清掃站數、淋巴結清掃數及術後疼痛評分比較差異均無統計學意義(P>0.05),但B組術後引流量明顯少于A組,術後引流時間明顯短于A組(P<0.05)。兩組治療前生活質量評分中軀體功能、角色功能、認知功能、情緒功能及社會功能比較差異均無統計學意義(P>0.05),接受術後4週時,兩組以上評分均得到有效改善,而B組明顯優于A組(P<0.05)。此外,兩組術後併髮癥髮生率比較差異無統計學意義(P>0.05)。結論:胸腔鏡肺癌術中先于清掃淋巴結可在不降低手術治療效果的同時,有效地改善患者的術後恢複情況。
목적:분석흉강경폐암술중선청소림파결치료적응용개치,이총결경위유효적흉강경폐암수술방안。방법:장60례의응용흉강경진행폐암수술치료적환자수궤분A조급B조,매조30례。A조술중선행종류절제후행림파결청소,B조술중선행림파결청소후행종류절제。대비량조술중급술후정황。결과:량조술중출혈량、수술시간、림파결청소참수、림파결청소수급술후동통평분비교차이균무통계학의의(P>0.05),단B조술후인류량명현소우A조,술후인류시간명현단우A조(P<0.05)。량조치료전생활질량평분중구체공능、각색공능、인지공능、정서공능급사회공능비교차이균무통계학의의(P>0.05),접수술후4주시,량조이상평분균득도유효개선,이B조명현우우A조(P<0.05)。차외,량조술후병발증발생솔비교차이무통계학의의(P>0.05)。결론:흉강경폐암술중선우청소림파결가재불강저수술치료효과적동시,유효지개선환자적술후회복정황。
Objective: To analyze the dissection value of first macroscopic lung cancer surgery treatment of lymph node,to summarize more effective macroscopic lung surgery program.Method:60 patients were to be applied macroscopic lung cancer surgery were randomly divided into group A and group B, 30 cases in each group.Group A in advance carried tumor excision, then cleaned lymph node, group B in advance cleaned lymph node then carried tumor excision.The cooperativeness and postoperative conditions of two groups were compared.Result:The blood loss, operating time, the number of stations lymph node dissection, the number of lymph node dissection and postoperative pain scores of the two groups were no significant differences (P>0.05), but postoperative drainage of the group B was significantly less than the group A, postoperative drainage time was significantly shorter the group A (P<0.05).Before treatment, while the quality of life scores in physical function, role function, cognitive function, emotional function and social function relatively of the two groups were no significant differences (P>0.05), while treatment after 4 weeks, the scores of the two groups had been effectively improved, while group B were significantly better than the group A (P<0.05). In addition, the incidence of postoperative complications of the two groups was no significant difference (P>0.05). Conclusion:Macroscopic lung cancer surgery in the lymph nodes before recovery can not reduce surgical treatment at the same time, effectively improve the postoperative patient.